Human T cells express various isoforms of CD45 (leukocyte common antigen), which arise from alternate mRNA splicing (1) . The mAb UCHLI recognizes a 180 kD molecular mass isoform, CD45RO (2). Recent studies on major two (CD4+ and CD8+) subpopulations of circulating T cells have suggested that UCHLI identifies a primed population of T cells that includes memory cells (3). Within CD4+ cells, the CD45RO population mediates proliferative responses to recall antigens and is able to support B cell differentiation . A reciprocal population of CD4+ cells, identified by mAbs to the 205-and 220-kD molecular mass isoforms termed CD45RA, do not show these capabilities. It has also been shown that the CD45RO population of CD8 + cells contains precursors exerting memory-dependent cytotoxicity (4).
chain (5) was the kind gift of Dr. L. Moretta (University ofGeneva, Italy). AntiTiyA mAb (IgG2a), generously provided by Dr. T. Hercend (Institut Gustave-Roussy, Villejuif, France), recognizes the human TCR--y molecule (6) . FITC-conjugated TCRSI mAb (IgGI) (7) and FITC-conjugated STCSI mAb (IgGI) (8) , both of which have been found to be directed to human TCR6 chains, were obtained from T Cell Sciences (Cambridge, MA) . FITC-conjugated anti-Leu-3a mAb (IgGI) specific for CD4 was from Becton Dickinson & Co. (Mountain View, CA) .
Immunofluorescence Analysis.
Viable mononuclear cells from heparinized blood were isolated on Ficoll/Hypaque gradients (Lymphoprep, Nycomed AS, Oslo, Norway) and stained with mAb. Two-color staining was performed to evaluate expression of CD45RO by TCR y/S' cells. The cells were first incubated with UCHL1 or isotype-matched control mouse IgG, and counterstained with biotinylated rabbit anti-mouse IgG2a antibody (Zymed Laboratories, San Francisco, CA), and further with phycoerythrin (PE)-conjugated streptavidin (Becton Dickinson & Co.). Next, the cells were stained for determination of TCR-y/S' cells with FITC-conjugated TCR61, FITC-conjugated 6TCSI, or unconjugated BB3 mAb . For BB3 staining, the cells were finally treated with FITC-conjugated horse anti-mouse IgGI antibody (Zymed Laboratories) . The labeled cells were analyzed by an Epics C flow cytometer (Coulter Electronics, Inc., Hialeah, FL).
Proliferative Responses.
TCRy/S' cell (TiyA' and STCSI') subsets were isolated using an Epics C flow cytometer from mononuclear cells stained with the corresponding mAbs as above. These cells were seeded on flat-bottomed microtiter plates (Corning Glass Works, Corning, NY) at 5 x 104 cells/well in 0.2 ml ofRPMI 1640 supplemented with 10% AB serum in the presence of 5 x 103 irradiated adherent monocytes from the same donor. Cultures were stimulated with 1 p,g/ml of purified protein derivative (PPD; Japan BCG Co., Ltd ., Tokyo, Japan) or 10 ng/ml of anti-CD3 mAb (OKT3 ; Ortho Pharmaceutical Co., Raritan, NJ) for 120 h and were pulsed with 0.5 EtCi of [3H]TdR 12 h before harvesting. As controls, the similar cultures were carried out for CD45RO' and CD45RO -CD4' cells separated by the cell sorting .
Results and Discussion
We used TCRSI mAb to examine the frequency of TCRy/S' cells and their expression of CD45RO, since TCRSI has been shown to detect the whole population of TCRy/S' cells (6) . The appearance of blood TCRy/S' cells was scarce (<0 .5%) at birth, gradually increased with age, and reached the adult values in older children (Table I) . On the other hand, the proportions of TCR a/a+ cells with C134 or CD8 in the neonatal blood are similar to those observed in the adult blood (9) . Consistent with the current concept of naive and memory T cells, we observed that the circulating pool of CD4 + and CD8+ cells expressing CD45RO increased as a function of age (unpublished observations). In adult subjects, the mean percentages of CD45RO' cells within CD4+ and CD8+ cells are 35 and 25%, respectively. In marked contrast to CD4+ and CD8+ cells, expression of CD45RO was observed on a sizable portion (N70%) of blood TCRy/S+ cells in all donors examined ( Table  I ). The remarkable finding was that most TCRy/S+ cells possessed CD45RO on their surfaces even around 1 mo of life shortly after birth. We often observed that some of donors exhibited a clear bimodal distribution of CD45RO expression on TCR-y/6`cells ( Fig . 1 A) . This suggests the presence of a small CD45RO-population of TCRy/S+ cells in blood. The recent availability of other mAb specific for human TCR-7/6 molecules have allowed to identify two mutually exclusive subsets defined by BB3 and STCS1 mAbs (5, 6) . In blood TCR y/S+ cells, most cells reacts with BB3, whereas a few cells are positive for 6TCS1. Based on our observations, we next asked whether expression of CD45RO by these two TCRy/S+ cells might be different from each other. Fig. 1 shows a representative of two-color immunofluorescence analysis for CD45RO expression by Ty/S + subsets. Interestingly, a large percentage of BB3+ cells were considered CD45RO', whereas CD45RO expression was absent from STCS1+ cells. As presented in Table  II , this was the rule in all of seven subjects studied . Although studies for established clones suggest that all TCR-y/b' cell clones mediate non-MHC-restricted cytotoxicity (10), the antigen-specificity and immunological functions of these cells remain speculative. On the basis of the correlation between CD45RO expression and memory T cells, it seemed feasible to suppose that BB3' cells, but not 6TCSI' cells lacking CD45RO, might contain a population responding to certain antigens in a similar manner to memory CD4' cells. Preliminary experiments suggested that staining with BB3 mAb for the cell sorting resulted in somewhat enhanced background responses of isolated cells, indicating the activation of corresponding subsets by this antibody (11) . It has been demonstrated that most BB3 + cells are identified by antiTiyA mAbs as well (12) . In addition, resting TiyA cells do not proliferate in response to anti TiyA mAb in the absence of exogenous IL-2 (13). Thus, we substituted antiTiyA for BB3 to isolate CD45RO' TCR y/b' subsets. As shown in Table III , both TiyA' and 6TCS1' cells proliferated well in response to anti-CD3 mAb. In PPD-reactive individuals, appreciable proliferative responses to PPD, though less than those seen in memory (CD45RO') CD4+ cells, were obtained only from TiyA' cells, but not from UCSI' cells. These results strongly suggest that a fraction of TiyA' cells may contribute the immune response to a nominal antigen. Since 95 % ofBB3 cells, though not completely identical, coexpress TiyA antigen (13), we speculate that functional profiles of TiyA' cells may represent those ofBB3 + cells. Regarding the antigen-specific response of TCR-y/b' cells, it has recently been reported that TCRy/b' clones established from blood lymphocytes respond to some antigens such as tetanus toxoid or PPD in a MHCrestricted fashion (14, 15) .
Moretta et al. (16) have indicated that BB3' cells express Cyl-encoded TCR--y/b heterodimers, whereas 6TCS1' cells express Cy2-encoded molecules. BB3' cells predominate in the peripheral blood, but are very scantily found in the thymic tissues. In contrast, BTCSI' cells are enriched in the thymus. Immunohistochemical analysis have shown that 6TCSI' cells are predominant in intraepithelial lymphocytes ofthejejunum as compared with the blood (17) . However, the reason for such different tissue distribution between BB3' and 6TCSI' cells is unknown. In conclusion, the present study showed that the BB3' subset in the peripheral blood selectively expressed CD45RO, corresponding with their responding capability to recall antigens . These observations implicate a special role of this subset in the immune response to many pathogens and infectious agents .
Summary
We examined the developmental profile of TCRy/S + cells with respect to CD45RO expression. Although total TCRy/S`cells were negligible in the neonatal blood and increased with advancing age, most blood TCR'r/S+ cells markedly expressed CD45RO without a distinction of age, probably reflecting a different CD45RO expression of two subsets defined by BB3 and STCSI mAbs . The vast majority of BB3+ cells expressed CD45RO, whereas expression of CD45RO was virtually absent in the STCSI + population . Functional studies revealed that, while both TCR y/S+ cell subsets showed CD3-mediated activation, only BB3 + (or TiyA + ) cells, but not STCSI + cells, appeared to proliferate in response to PPD in PPD-reactive individuals. The results suggested that the CD45RO' (BB3 + or TiyA+) subset among blood TCR-y/b+ cells may be mainly involved in the memory or primed component of the immune system responding to some foreign antigens . 
